Evolus Inc

EOLSNASDAQ · USD
7.96USD-0.29 (-3.52%)
259

Evolus Inc (EOLS) Option Chain

As of September 22, 2026, Evolus Inc is trading at $7.96, a -3.52% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 101.4%. IV Rank is 50%.

Read more

Tracking the EOLS option chain helps you see every strike and expiry on Evolus Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Evolus Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of EOLS options activity at a glance. Use our scanner to monitor the EOLS option chain in real time and filter for the EOLS options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For EOLS stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the EOLS option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where EOLS stock options are being actively traded and where they are not.

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Evolus Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen EOLS options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of EOLS stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryDrug Manufacturers - Specialty & Generic
  • SectorHealthcare
  • IV percentile59.13% Neutral
  • Market cap (M$)545
  • 52 weeks high-11.39%
  • 52 weeks low113.73%
  • Analyst recommendationStrong Buy
    1.33
  • Target price$15.00
    88.44% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-04
  • P/E
  • Future P/E32.35
  • EPS (ttm)-0.53
  • EPS growth next 5 years

As of September 22, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.001600.095.463.108.002.50-68.191.750.001.7500100.00
0.262500.092.962.303.805.00-36.390.050.000.05218899.74
40.7224960.340.460.501.107.50-4.580.050.400.000.2305259.28
94.2824310.100.000.1010.00+27.231.452.752.040.06005.72
99.86001.200.001.2012.50+59.033.705.304.54-0.04000.14

As of September 22, 2026

Scan the full option chain in one place

Browse the full EOLS option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial